年龄与重性抑郁障碍病程的关联:一项2年纵向队列研究
该研究基于NESDA与NESDO两个队列的1042名基线重性抑郁障碍(MDD)患者,纵向随访2年,发现年龄越大,MDD的2年病程越差,且呈线性恶化,70岁及以上人群结局最差;调整临床、社交与健康因素后结果略减弱但仍多显著。
核心结论
- 年龄较大是MDD 2年病程较差的持续且重要风险因素,且不能由已确立的多项风险因素完全解释。
研究设计与样本
- 纵向队列研究,使用NESDA与NESDO队列的基线与2年随访数据,纳入18至88岁基线MDD诊断且有2年有效临床评估者1042人,其中女性690人(66%)。
主要发现
- 调整预后临床、社交与健康因素后,上述结果略有减弱但多数仍显著。
关键数值与推荐
- 主要结局为2年MDD病程,采用四项指标评估:2年后仍符合抑郁诊断(MDD或恶劣心境)、慢性症状病程(2年随访期间80%及以上时间存在抑郁症状)、缓解时间、抑郁严重度变化。
- 采用多变量分析检验连续年龄与MDD病程指标的关联,并检验预后临床(如共病焦虑)、社交(孤独感与社会支持)与健康(体质指数、疼痛、慢性疾病)因素的贡献。
临床怎么用
- 对年龄较大的MDD患者应重视其更差的长期病程风险,尤其70岁及以上人群,需加强随访与全程管理。
- 临床评估中可关注共病焦虑、孤独感、社会支持、体质指数、疼痛与慢性疾病等预后相关因素,但其不能完全解释年龄相关病程差异。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although there is some evidence that older people might have a poorer course of major depressive disorder (MDD) than younger or middle-aged people, and that age-related course differences might affect the optimisation of MDD treatment, large-scale studies with a broad age range, including consistent course assessments, are needed to properly address this issue. Therefore, we aimed to longitudinally examine whether older age was associated with a poorer naturalistic course trajectory of MDD than that of younger ages and to establish which prognostic-clinical, social, and health-factors could explain this potentially poorer course. METHODS: For this longitudinal cohort study, we used baseline and 2-year follow-up data from the Netherlands Study of Depression and Anxiety (NESDA) and the Netherlands Study of Depression in Older Persons (NESDO) cohorts. People aged between 18 and 88 years, with an MDD diagnosis at baseline, and a valid clinical assessment at 2-year follow-up were included. The primary outcome was the 2-year course of MDD, which was assessed by use of four indicators: having a depression diagnosis (MDD or dysthymia) after 2 years, having a chronic symptom course (depressive symptoms present during 80% or more of the 2-year follow-up period), time to remission, and depression severity change. We used multivariate analyses to examine associations between continuous age and these MDD course indicators. We also examined whether prognostic clinical (eg, comorbid anxiety), social (loneliness and social support), and health (body-mass index, pain, and chronic diseases) factors contributed to the differences in the course of MDD between age groups. FINDINGS: Between 2004-2012, baseline and 2-year follow-up data were obtained for 1042 participants from the NESDA and NESDO cohorts, of whom 690 (66%) were women. Older age was significantly associated with a worse 2-year MDD course for all four indicators (MDD diagnosis: odds ratio [OR] 1·08, 95% CI 1·00-1·17; chronic symptom course: OR 1·24, 1·13-1·35; time to remission: hazard ratio [HR] 0·91, 0·87-0·96; and depression severity change: regression coefficient 1·06, p<0·0001; all per 10-year increase). The course of MDD worsened linearly with age, and people aged 70 years or older had the worst outcomes compared with those of the reference group of people aged 18-29 years (MDD diagnosis: OR 2·02, 95% CI 1·18-3·45; chronic symptom course: OR 3·19, 1·74-5·84; time to remission: HR 0·60, 0·44-0·83; and depression severity change: -12·64 [SD 10·85] in those aged 18-29 years and -5·57 [11·14] in those aged 70 years or older). These results were slightly reduced, but remained mostly significant when adjusting for prognostic clinical, social, and health factors. INTERPRETATION: Older age was found to be a consistent and important risk factor for a poorer MDD course, which could not be explained by a range of well established risk factors. Further investigation of potential underlying mechanisms-including the effect of cognitive impairment, for example-is needed to prevent the negative consequences of a long-term MDD burden in older people. FUNDING: Netherlands Organisation for Health Research and Development, Fonds NutsOhra, Stichting tot Steun VCVGZ, NARSAD The Brain and Behaviour Research Fund, and European Union's 7th Framework Programme.
引用
- Schaakxs R, Comijs HC, Lamers F, et al. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study. Lancet Psychiatry. 2018. PMID: 29887519. doi:10.1016/S2215-0366(18)30166-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。